ArticleFrontiers in public health2025
The burden of low back pain in BRICS: an analysis for the global burden of disease study 2021.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The Knowledge-to-Practice Gap in Safe Lifting and Biomechanical Risks as Determinants of Musculoskeletal Disorders in Manual Material Handling.International journal of environmental research and public health · 2026Article
- Evolving Landscape of Regenerative Therapies: Cell-Based and Cell-Free Approaches for Chronic Low Back Pain.Journal of clinical medicine · 2026Review
- Burden and Trends of Low Back Pain in Pakistan: A Global Burden of Disease Study, 1990-2021.Cureus · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To analyze the development of low back pain (LBP) disease burden in BRICS countries (Brazil, Russia, India, China and South Africa) from 1990 to 2021 and provide a scientific basis for China and its partner countries to carry out low back pain prevention and transnational medical cooperation. Methods: The burden of disease for low back pain was assessed by analyzing morbidity, prevalence, years lived with disability (YLD), and other disease burden indicators in BRICS countries in the Global Burden of Disease (GBD) Study from 1990 to 2021. The average annual percentage change (AAPC) was calculated using the Joinpoint regression model. Disease burden and risk factor attribution trends for patients with low back pain in BRICS countries were analyzed from 1990 to 2021. The Bayesian age-period-cohort (BAPC) model was used to predict and analyze future trends in low back pain globally and in BRICS countries. Results: The age-standardized incidence rate (ASIR) and age-standardized years lived with disability (ASYLD) for low back pain have generally decreased in China and India, while they have increased in Russia, Brazil, and South Africa. In 2021, the ASIR for low back pain in China was 2,342.46, and the ASYLD was 603.04, with decreases of 26.20 and 26.03%, compared to 1990. In Russia, the ASIR for low back pain in 2021 was 4,529.36, and the ASYLD was 1,206.23, an increase of 16.75 and 15.62% over 1990. In Brazil, the ASIR in 2021 was 3,873.61, and the ASYLD was 1,034.20, representing increases of 19.97 and 21.84%, respectively, compared to 1990. In 2021, the ASIR and ASYLD for low back pain are rising in South Africa, at 2,753.32 and 693.46, with the indices of the increasing trends being 5.46 and 3.04%, respectively, compared to 1990. All the differences observed were statistically significant ( Conclusion: From 1990 to 2021, the burden of low back pain declined in China and India, but morbidity and disability-adjusted life years (DALY) remained high. Russia, Brazil, and South Africa are on the rise, and health research on LBP needs to be intensified. Females and the older adult are at high risk of low back pain. Occupational ergonomics and high body mass index (BMI) are major risk factors affecting BRICS countries. The global incidence of LBP from 1990 to 2030 presents a significant downward trend in the future for males and a slight upward trend for females, with an overall global decline.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.